ExploreWatchlistsPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. Total current assets

JCR Pharmaceuticals Co.,Ltd. (4552)

Market cap
¥73.8B
P/E ratio
43.4x
JCR Pharma develops and manufactures pharmaceutical and regenerative medicine products for healthcare providers worldwide, with specialized focus on advanced regenerative treatments.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
Mar 31, 202551,056-11.33%
Mar 31, 202457,581+20.46%
Mar 31, 202347,802-23.13%
Mar 31, 202262,188+28.10%
Mar 31, 202148,545+71.28%
Mar 31, 202028,342+3.56%
Mar 31, 201927,368+17.32%
Mar 31, 201823,327+14.83%
Mar 31, 201720,315+10.61%
Mar 31, 201618,366+6.84%
Mar 31, 201517,191

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat